Search results
Results from the WOW.Com Content Network
Emerging technologies are those technical innovations which represent progressive developments within a field for competitive advantage; [2] converging technologies represent previously distinct fields which are in some way moving towards stronger inter-connection and similar goals. However, the opinion on the degree of the impact, status and ...
A biologist conducting research in a biotechnology laboratory. Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services. [1]
This is a list of emerging technologies, which are in-development technical innovations that have significant potential in their applications. The criteria for this list is that the technology must: Exist in some way; purely hypothetical technologies cannot be considered emerging and should be covered in the list of hypothetical technologies ...
The historical application of biotechnology throughout time is provided below in chronological order.. These discoveries, inventions and modifications are evidence of the application of biotechnology since before the common era and describe notable events in the research, development and regulation of biotechnology.
On October 10, 2016, the Forum announced the opening of its Centre for the Fourth Industrial Revolution in San Francisco. [14] According to Schwab, fourth era technologies includes technologies that combine hardware, software, and biology (cyber-physical systems), [15] and which will put an emphases on advances in communication and connectivity.
Conversely, many new medical technologies involving nanoparticles as delivery systems or as sensors would be examples of nanobiotechnology since they involve using nanotechnology to advance the goals of biology. The definitions enumerated above will be utilized whenever a distinction between nanobio and bionano is made in this article.
These debates gained exposure in 1975 at the Asilomar Conference, where Joshua Lederberg was the most outspoken supporter for this emerging field in biotechnology. By as early as 1978, with the development of synthetic human insulin , Lederberg's claims would prove valid, and the biotechnology industry grew rapidly.
The new technology itself can interact with other technologies to form a new technology again. As the process of combining existing technologies is repeated again and again, the network of technologies grows. A described mechanism of technological change has been termed, “combinatorial evolution”. [2]